Effect of GLP-1 on Angiogenesis, Angiosafe Type 2 Diabetes Study 1

Trial Profile

Effect of GLP-1 on Angiogenesis, Angiosafe Type 2 Diabetes Study 1

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Jun 2016

At a glance

  • Drugs Liraglutide (Primary) ; Metformin; Sulfonylureas
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Proof of concept
  • Acronyms ANGIOSAFE 1
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Jun 2016 Last checked against the ClinicalTrials.gov record.
    • 30 May 2016 Planned End Date changed from 1 Apr 2019 to 1 Jun 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top